Skip to content

Effect of Bupivacaine Liposome used for External Oblique Intercostal Block on Postoperative Analgesia and Rehabilitation of Patients with Partial Hepatectomy

Effect of Bupivacaine Liposome used for External Oblique Intercostal Block on Postoperative Analgesia and Rehabilitation of Patients with Partial Hepatectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104501
Enrollment
Unknown
Registered
2025-06-18
Start date
2025-03-12
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver diseases

Interventions

Liposomal Bupivacaine-Applied External Oblique Intercostal Plane Block Group:After the patient was under general anesthesia, ultrasound-guided external oblique intercostal plane (EOIP) block was perf
Ropivacaine-Applied External Oblique Intercostal Plane (EOIP) Block Group:After the patient was under general anesthesia, ultrasound-guided external oblique intercostal plane (EOIP) block was performe

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Patients scheduled for elective partial hepatectomy under general anesthesia; (2) No gender restriction; Aged 18-65 years; BMI 18.5-28 kg/m²; ASA (American Society of Anesthesiologists) class I or II; (3) Provision of written informed consent; (4) Normal preoperative cardiac, hepatic, pulmonary, and renal function in all patients; (5) Intact cognitive function.

Exclusion criteria

Exclusion criteria: (1) Patients with anatomic abnormalities or a history of previous upper abdominal surgery; (2) Infection at the puncture site; (3) Coagulopathy or platelet disorders; history of bleeding tendency or hematologic diseases; (4) Concurrent surgery at other sites; (5) Allergy to local anesthetics; (6) Chronic use of analgesics; (7) Severe respiratory or cardiovascular diseases; (8) Severe hepatic or renal dysfunction; (9) Preoperative impairment of consciousness or cognitive dysfunction;

Design outcomes

Primary

MeasureTime frame
Cumulative opioid consumption within 72 hours postoperatively;

Secondary

MeasureTime frame
Highest reported resting and coughing NRS pain scores in the PACU;Resting and coughing NRS pain scores at 4h, 8h, 16h, 24h, 48h, and 72h postoperatively Key refinements;Time to first rescue analgesia postoperatively;Number of rescue analgesia administrations, analgesic types, and total dosages within 72 hours postoperatively;Time to first PCA demand and total number of effective demands within 72 hours postoperatively;Heart rate (HR) and blood pressure (BP) at the following time points: Pre-induction of general anesthesia ,Surgical incision ,1 hour after surgery commencement;Total intraoperative opioid consumption;QoR-15 scores at preoperative 24h, postoperative 24h, 48h, and 72h;PSQI scores on the day before surgery, the day of surgery, and the second day after surgery;Time to first flatus and ambulation after surgery;

Countries

China

Contacts

Public ContactZhang Xuekang

The First Affiliated Hospital of Nanchang University

kang7139@163.com+86 138 7063 9612

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026